On October 1, 2026, Greenwich Rx initiated a Class I recall of its Glutathione Injection, which is classified as the most serious type of recall. The recall affects the 200 mg/mL, 10 mL multi-dose vial, which is intended for subcutaneous use only and is available by prescription.

According to the Food and Drug Administration, the recall was prompted by microbial contamination of sterile products. The recall is ongoing and affects distribution across the United States.

Press Release: Food and Drug Administration

Published October 28, 2026. Reproduced in full from the Food and Drug Administration.

Greenwich Rx drug recall

  • Recalling company: Greenwich Rx
  • Classification: Class I (the most serious type)
  • Recall numbers: D-0084-2027
  • Status: Ongoing
  • Distribution: US Nationwide in th USA
  • Recall started: October 1, 2026

What was recalled

Glutathione Injection (Glutathione-L, Ascorbic Acid, Sodium Hydroxide, Bacteriostatic Water), 200 mg/mL, 10 mL multi-dose vial, Rx only, Subcutaneous Only, Greenwich Rx.

Why

Microbial Contamination of Sterile Products

This drug recall appears in the FDA's weekly enforcement report. Details: FDA recall event 100004.